HPV

16 all articles · 20 / page

Ask MedXY AI

Latest news

Tag

All articles

news

Enhancing Triage of Non-16/18 High-Risk HPV Cervical Lesions Using FAM19A4, SOX1, and PAX1 Methylation Testing

By MedXY|Jun 25, 2026

FAM19A4, SOX1, and PAX1 methylation assays demonstrate high diagnostic accuracy for identifying CIN3+ among non-16/18 hrHPV-positive women, outperforming cytology and reducing unnecessary colposcopies.

news

HPV

Latest news

Enhancing Triage of Non-16/18 High-Risk HPV Cervical Lesions Using FAM19A4, SOX1, and PAX1 Methylation Testing

Impact of Immunocompromise on Survival in HPV-Positive Throat Cancer Patients

New Cervical Cancer Screening Guidelines: Patient-Collected HPV Tests Now Recommended

Saturated Saline Immersion: A Novel and Noninvasive Approach for Refractory Plantar Warts

HPV-Positive Oropharyngeal Cancer Retains a Strong Survival Advantage After Surgery in Patients Aged ≥70

Unilateral TORS for HPV-Positive Tonsillar Cancer Appears Safe — Bilateral Contralateral Tonsillectomy May Add Harm Without Clear Benefit

Evaluating Self-Collected Urine and Vaginal Samples for HPV Genotyping in Cervical Cancer Screening Among Japanese Women

Review for Cervical Cancer Screening

Epstein-Barr Virus Serology as a Predictor of Persistent Oral HPV Infection in Men: Insights From the Finnish Family HPV Study

Impact of Epstein-Barr Virus Serology on Oral HPV Infection Dynamics in Early Childhood: Insights from the Finnish Family HPV Cohort

Beyond Cervical Cancer: The Rising Threat of HPV-Linked Oropharyngeal Cancer in Men

Six Early Warning Signs Your Body May Be Sending: Precancerous Conditions to Notice and Act On

Long-Term Outcomes of Transoral Surgery with Risk-Adapted Adjuvant Therapy in HPV-Positive Oropharyngeal Cancer: Results from the E3311 Trial

Cervical Cancer Risk After 65: Why Continued Screening Matters

Evaluating HPV Vaccination Schedules: A New Perspective on Booster Doses

Understanding HPV Infections: Risks and Realities